Clinical Trials at New England Cancer Specialists
As of September 2026, 15 paid clinical trials are recruiting at New England Cancer Specialists, located at New England Cancer Specialists - Rock Row, 11 Rock Row, Westbrook, ME 04092, phone (207) 303-3300 in Westbrook, Maine. Active studies at this site cover conditions such as Breast Neoplasms, Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
15 clinical trials at New England Cancer Specialists
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Common conditions studied in Westbrook
- Breast Neoplasms (4 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (1 active study)
- Breast Cancer (1 active study)
Leading research sponsors in Westbrook
- Merck Sharp & Dohme LLC
- Amgen
- Eli Lilly and Company
- BeOne Medicines
- BioNTech SE
Frequently asked questions
How many paid clinical trials are currently recruiting in Westbrook?
There are approximately 16 recruiting clinical trials in Westbrook, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Westbrook pay participants?
Most recruiting trials in Westbrook compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Westbrook?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Westbrook?
The most common conditions under active study in Westbrook include Breast Neoplasms (4), Anatomic Stage I Breast Cancer AJCC v8 (1), Anatomic Stage II Breast Cancer AJCC v8 (1), Anatomic Stage IIIA Breast Cancer AJCC v8 (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Westbrook?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Westbrook on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Westbrook?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Westbrook?
Recruiting research sites in Westbrook include New England Cancer Specialists, Study, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Westbrook right now?
The largest active categories in Westbrook are Cancer & tumors (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of New England Cancer Specialists?
New England Cancer Specialists is located at New England Cancer Specialists - Rock Row, 11 Rock Row, Westbrook, ME 04092. Use the Google Maps link in the intro above to get directions.
How do I contact New England Cancer Specialists?
You can reach New England Cancer Specialists by phone at (207) 303-3300. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.